These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8378258)

  • 1. Low molecular weight proteins as carriers for renal drug targeting: naproxen coupled to lysozyme via the spacer L-lactic acid.
    Franssen EJ; Moolenaar F; de Zeeuw D; Meijer DK
    Pharm Res; 1993 Jul; 10(7):963-9. PubMed ID: 8378258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates.
    Franssen EJ; Koiter J; Kuipers CA; Bruins AP; Moolenaar F; de Zeeuw D; Kruizinga WH; Kellogg RM; Meijer DK
    J Med Chem; 1992 Apr; 35(7):1246-59. PubMed ID: 1560438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low molecular weight proteins as carriers for renal drug targeting: naproxen-lysozyme.
    Franssen EJ; van Amsterdam RG; Visser J; Moolenaar F; de Zeeuw D; Meijer DK
    Pharm Res; 1991 Oct; 8(10):1223-30. PubMed ID: 1796038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-targeting to the kidney: renal delivery and degradation of a naproxen-lysozyme conjugate in vivo.
    Haas M; Kluppel AC; Wartna ES; Moolenaar F; Meijer DK; de Jong PE; de Zeeuw D
    Kidney Int; 1997 Dec; 52(6):1693-9. PubMed ID: 9407519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic and intrahepatic targeting of an anti-inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules.
    Franssen EJ; Jansen RW; Vaalburg M; Meijer DK
    Biochem Pharmacol; 1993 Mar; 45(6):1215-26. PubMed ID: 8466542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of dendrimer prodrugs for oral drug delivery.
    Najlah M; Freeman S; Attwood D; D'Emanuele A
    Int J Pharm; 2007 May; 336(1):183-90. PubMed ID: 17188439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of naproxen covalently linked to HSA to sinusoidal cell types of the liver.
    Melgert BN; Wartna E; Lebbe C; Albrecht C; Molema G; Poelstra K; Reichen J; Meijer DK
    J Drug Target; 1998; 5(5):329-42. PubMed ID: 9771615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal targeting of a non-steroidal anti-inflammatory drug: effects on renal prostaglandin synthesis in the rat.
    Haas M; Moolenaar F; Meijer DK; de Jong PE; de Zeeuw D
    Clin Sci (Lond); 1998 Nov; 95(5):603-9. PubMed ID: 9791047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific delivery of captopril to the kidney with the prodrug captopril-lysozyme.
    Kok RJ; Grijpstra F; Walthuis RB; Moolenaar F; de Zeeuw D; Meijer DK
    J Pharmacol Exp Ther; 1999 Jan; 288(1):281-5. PubMed ID: 9862782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic studies of naproxen amides of some amino acid esters with promising colorectal cancer chemopreventive activity.
    Aboul-Fadl T; Al-Hamad SS; Fouad EA
    Bioorg Chem; 2018 Feb; 76():370-379. PubMed ID: 29241109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug delivery to the kidneys and the bladder with the low molecular weight protein lysozyme.
    Kok RJ; Haas M; Moolenaar F; de Zeeuw D; Meijer DK
    Ren Fail; 1998 Mar; 20(2):211-7. PubMed ID: 9574445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and ulcerogenic studies of naproxen prodrugs designed for specific brain delivery.
    Sheha M
    Arch Pharm Res; 2012 Mar; 35(3):523-30. PubMed ID: 22477200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting naproxen coupled to human serum albumin to nonparenchymal cells reduces endotoxin-induced mortality in rats with biliary cirrhosis.
    Albrecht C; Meijer DK; Lebbe C; Sägesser H; Melgert BN; Poelstra K; Reichen J
    Hepatology; 1997 Dec; 26(6):1553-9. PubMed ID: 9397997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octadecylamine-Mediated Versatile Coating of CoFe2O4 NPs for the Sustained Release of Anti-Inflammatory Drug Naproxen and in Vivo Target Selectivity.
    Georgiadou V; Makris G; Papagiannopoulou D; Vourlias G; Dendrinou-Samara C
    ACS Appl Mater Interfaces; 2016 Apr; 8(14):9345-60. PubMed ID: 26984632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic bile duct obstruction and LPS upon targeting of naproxen to the liver using naproxen-albumin conjugate.
    Albrecht C; Melgert BN; Reichen J; Poelstra K; Meijer DK
    J Drug Target; 1998; 6(2):105-17. PubMed ID: 9886235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of low-molecular weight protein (LMWP) lysozyme-curcumin conjugates for kidney drug targeting.
    Wang Y; Sun Y; Wang H; Liu P; Peng W; Duan Y
    J Biomater Sci Polym Ed; 2013; 24(11):1360-7. PubMed ID: 23796036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation between naproxen, naproxen-protein conjugates, and naproxen-lysine in plasma via micellar electrokinetic capillary chromatography--a new approach in the bioanalysis of drug targeting preparations.
    Albrecht C; Reichen J; Visser J; Meijer DK; Thormann W
    Clin Chem; 1997 Nov; 43(11):2083-90. PubMed ID: 9365392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of captopril to the kidney reduces renal angiotensin-converting enzyme activity without affecting systemic blood pressure.
    Kok RJ; Haverdings RF; Grijpstra F; Koiter J; Moolenaar F; de Zeeuw D; Meijer DK
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1139-43. PubMed ID: 12023548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel brain targeting prodrugs of naproxen based on dimethylamino group with various linkages.
    Zhang Q; Liang Z; Chen LY; Sun X; Gong T; Zhang ZR
    Arzneimittelforschung; 2012 Jun; 62(6):261-6. PubMed ID: 22407924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low molecular weight proteins and dextran on renal cathepsin B and L activity.
    Olbricht CJ; Gutjahr E; Cannon JK; Irmler H; Tisher CC
    Kidney Int; 1990 Mar; 37(3):918-26. PubMed ID: 1690311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.